Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19).
Where this comes from
- Record sourced from PubMed, PMID 35026789.
- Also identified by DOI 10.1097/AOG.0000000000004700 and PMC identifier 8936149.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).
Medical subject headings
- COVID-19